SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership aimed at significantly reducing production costs and expanding capacity, which has driven substantial intraday stock volatility. The community is actively discussing the stock's low float and high trading volume, fueling speculation about a potential short squeeze and anticipating further upward movement as it tests key resistance levels. This partnership is seen as a crucial step for scaling their fingerprint drug screening technology ahead of anticipated future market expansion.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending within a volatile low-float SPAC sector, fueled by discussions surrounding its extremely tight share float and high insider ownership. The community is actively debating its potential for rapid price movement and a short squeeze, drawing comparisons to other recently surging SPACs as new utility via a planned reward token is also highlighted.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending strongly after securing FDA approval for NEREUS, its motion-sickness treatment, which is seen as the first new pharmacologic option in decades. The community is actively discussing the drug's significant potential in addressing GLP-1 induced nausea, fueling speculation of a major pharmaceutical buyout and leading many to view the stock as currently undervalued. With additional pipeline approvals anticipated, traders are closely watching for sustained momentum as the market fully integrates this landmark development.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to a significant price drop following an FDA Complete Response Letter for its relacorilant drug for Cushing syndrome, with the agency requesting additional efficacy evidence. Community discussion is polarized, with some investors calling the sell-off an overreaction given the company's existing profitable drug Korlym and other pipeline assets. The immediate focus is on whether the company can quickly find a path forward with the FDA and if current levels present a "bargain biobuy" or a "falling knife."

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid a significant price drop, sparking a highly polarized community debate. While many express extreme bearishness, labeling it a "scam" and predicting further declines, a resilient group views current lows as a buying opportunity, citing its ISO compliance, recent network upgrades, and potential for institutional adoption. The broader crypto market sentiment continues to heavily influence discussions around XLM's future trajectory.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after a competitor's drug for Cushing's syndrome received a regulatory setback from the FDA, which the community views as a significant advantage for Xeris's approved treatment, Recorlev. This development is seen as clearing the path for Recorlev to gain market share, fueling discussions among investors about the company's long-term growth potential and undervaluation, supported by positive analyst outlooks.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin (LTC) is currently trending, fueled by reports highlighting its "digital silver" status and recent outperformance, alongside discussions of an upcoming EzFill integration. The community expresses mixed sentiment, with some frustrated by its price action while many uphold strong long-term bullish convictions for its foundational role. Ongoing anticipation for Grayscale's potential ETF and future growth further drives conversation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is surging due to recent FDA updates, including priority review acceptance for AXS-05 for Alzheimer's disease agitation and positive pre-NDA meeting minutes supporting an AXS-12 submission for narcolepsy. The community is celebrating these significant advancements, seeing them as key catalysts driving the company toward profitability and anticipating further growth in its CNS portfolio.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the extension of China's NEV trade-in subsidies into 2026 fuels optimism across the sector, coinciding with an upbeat Q4 sales forecast from management suggesting potential profitability. While bulls are aggressively buying recent dips and anticipating a strong year-end, skeptics remain wary of past volatility and alleged market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Plains All American Pipeline (PAA) has agreed to sell its entire Canadian natural gas liquids (NGL) business to Keyera for about C$5.15 billion ($3.75 billion), as it aims to focus more on crude oil transportation.The assets include more than 1,500 miles of pipeline infrastructure, which have a combined capacity of 575,000 barrels per day (bbl/d), Calgary-based Keyera said.The deal, expected to close in the first quarter of 2026, will also cost $360 million in taxes to Plains.“With core NGL infrastructure in Alberta, the combined platform enables access to high-demand markets through Liquefied Petroleum Gas export access on the West Coast, while also reaching key consumption hubs in eastern Canada and the United States,” Keyera said in a statement.Keyera CEO Dean Setoguchi told Bloomberg News that the companies have been negotiating the deal for six months, but Keyera has been interested in the Plains assets for the past decade.The Canadian firm was able to move forward with the deal after paying down about C$500 million of debt, Setoguchi reportedly said.The transaction is expected to be accretive to distributable cash flow (DCF) per share, delivering mid-teens percentage accretion in the first full year, Keyera said in a statement.Following the closing of the deal, Plains will retain substantially all NGL assets in the United States and will also keep all crude oil assets in Canada.<a href="https://stocktwits.com/symbol/PAA">Plains All American stock </a>has risen 3.7% this year, while Plains GP, which holds a controlling interest in the company, is up 2.2%.Several U.S. energy companies have been exiting Canada to focus on their domestic operations. There are also concerns over the export of oil and other energy commodities to the U.S., as the Trump administration has imposed a 10% tariff on them. &nbsp;Retail sentiment on Stocktwits was ‘neutral’ (54/100), while retail chatter was ‘high’.<figure class="image"><img style="aspect-ratio:798/108;" src="https://news.stocktwits-cdn.com/PAA_June_18_JPG_000cb57b0d.webp" alt="PAA’s Sentiment Meter and Message Volume as of 03:55 a.m. ET on June 18, 2025 | Source: Stocktwits" width="798" height="108"><figcaption>PAA’s Sentiment Meter and Message Volume as of 03:55 a.m. ET on June 18, 2025 | Source: Stocktwits</figcaption></figure>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/japan-still-won-t-rush-into-us-trade-deal-says-pm-ishiba/chlrD4wRRcr">Japan Still Won’t Rush Into US Trade Deal, Says PM Ishiba — Even As Falling Exports Stoke Recession Risk</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of two businessmen shaking hands after a deal.

Plains All American Sells Canadian NGL Business To Keyera For $3.75B

The assets include more than 1,500 miles of pipeline infrastructure, which have a combined capacity of 575,000 barrels per day.

Equity

Williams Co (WMB) was in focus on Monday after the company said it would invest about $1.6 billion to provide an unnamed firm with committed power generation and associated gas pipeline infrastructure.The pipeline operator said that, assuming the permits are received in a timely manner, the project is expected to be completed in the second half of 2026.Williams said that the project is backed by a 10-year, primarily fixed-price power purchase agreement, with an option for the investment-grade customer to extend it. The firm did not reveal the project's location in the regulatory filing.The company said it would raise its growth capital expenditure by $925 million to a new total between $2.58 billion and $2.88 billion.“This is the company’s first power innovation project to deliver speed-to-market solutions for growing demand in grid-constrained markets,” Williams said.Power demand in the U.S. has surged recently, backed by increased consumption from artificial intelligence data centers.According to a Lawrence Berkeley National Laboratory report, data centers are expected to consume between 6.7% and 12% of total U.S. electricity by 2028, up from 4.4% in 2023.In 2024, the company had announced six transmission projects to add 885 million cubic feet per day (mmcf/d) of capacity to serve key demand centers.In February, Williams had topped Wall Street’s quarterly profit and revenue estimates, aided by contributions from newly acquired assets.The company had also raised its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) forecast by 3% at the midpoint to $7.65 billion.Retail sentiment on Stocktwits remained in the ‘bullish’ (55/100) territory, while retail chatter was ‘low.’<figure class="image"><img style="aspect-ratio:735/164;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/WMB_March_3_df8bcf5832.JPG" alt="WMB’s Sentiment Meter and Message Volume as of 10:55 p.m. ET on March 3, 2025 | Source: Stocktwits" width="735" height="164"><figcaption>WMB’s Sentiment Meter and Message Volume as of 10:55 p.m. ET on March 3, 2025 | Source: Stocktwits</figcaption></figure>Over the past year, <a href="https://stocktwits.com/symbol/WMB">Williams stock</a> has gained 58.2%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/oil-stocks-feel-the-heat-as-opec-proceeds-with-production-raise-retail-s-still-bullish/chej4LkRC2">Oil Stocks Feel The Heat As OPEC+ Proceeds With Production Raise, Retail’s Still Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

North Dakota, Williams Pipeline Company, petroleum storage. (Photo by: Jeff Greenberg/Universal Images Group via Getty Images)

Williams Stock In Spotlight On $1.6B Investment For New Energy Infrastructure Project, Retail’s Bullish 

The company said the project is backed by a 10-year, primarily fixed-price power purchase agreement, with an option for its investment-grade customer to extend it.

Kinder Morgan (KMI) stock garnered retail attention on Thursday after the company fell short of the Wall Street estimate for fourth-quarter profit.On Wednesday, the company reported adjusted net earnings of $0.32 per share, narrowly missing the average analysts’ estimate of $0.33 per share, according to Koyfin data.The energy pipeline operator’s fourth-quarter revenue fell to $3.99 billion from $4.04 billion last year, driven by a 7% fall in natural gas gathering volumes primarily from Haynesville and Bakken due to lower commodity prices.However, the natural gas pipelines segment's core earnings rose compared to last year, driven by higher contributions from its Texas Intrastate system and additional contributions from its STX Midstream acquisition.Kinder Morgan also said it would build a 216-mile pipeline named Trident Intrastate, carrying about 1.5 billion cubic feet of natural gas from Katy to the liquefied natural gas corridor near Port Arthur in Texas.The project announcement follows U.S. President Donald Trump’s executive order on Monday, which lifted the pause on new liquefied natural gas permits imposed by the Biden administration.The Houston-based firm aims to capitalize on a surge in natural gas demand, also driven by artificial intelligence data centers. At the end of the quarter, it had a project backlog of $8.1 billion. &nbsp;The company said its total refined products transport volumes were up 2%, and crude and condensate volumes were down 5% compared to the fourth quarter of 2023.<a href="https://stocktwits.com/symbol/KMI">Kinder Morgan</a> forecasted its 2025 net income to rise 8% to $2.8 billion.“With robust market fundamentals and a new (Presidential) Administration committed to expediting energy infrastructure projects, the future looks bright,” Executive Chairman Richard D. Kinder said.Shares of the company rose 0.4% in pre-market trade.Retail sentiment on Stocktwits dipped to ‘neutral’ (54/100) from ‘extremely high’(93/100) a day ago, while retail chatter soared to ‘extremely high.’<figure class="image"><img style="aspect-ratio:802/180;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/KMI_Jan_23_8b29497481.JPG" alt="KMI’s Sentiment Meter and Message Volume as of 07:26 a.m. ET on Jan. 23, 2025 | Source: Stocktwits" width="802" height="180"><figcaption>KMI’s Sentiment Meter and Message Volume as of 07:26 a.m. ET on Jan. 23, 2025 | Source: Stocktwits</figcaption></figure>Users' comments were also divided, with some remaining bullish and some skeptical about the stock’s valuation.<stembedurl>https://stocktwits.com/ExcelBull25/message/601083727</stembedurl><stembedurl>https://stocktwits.com/Gibby33/message/601093130</stembedurl><stembedurl>https://stocktwits.com/Mikemike8686/message/601095767</stembedurl>Over the past year, the stock has gained nearly 79%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/procter-and-gamble-stock-surges-on-q2-earnings-beat-retail-cheers/chbBUm0R81">Procter &amp; Gamble Stock Surges On Q2 Earnings Beat: Retail Cheers</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Kinder Morgan, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on January 5, 2025. (Photo by Jaque Silva/NurPhoto via Getty Images)

Kinder Morgan Stock In Spotlight After Q4 Earnings Miss: Retail’s Undecided

The midstream firm said it would build a 216-mile pipeline named Trident Intrastate, carrying about 1.5 billion cubic feet of natural gas from Katy to the liquefied natural gas corridor near Port Arthur in Texas.

MLPX
Global X Funds - Global X MLP & Energy Infrastructure ETF

Feed

News

Sentiment

Fundamentals

Info

Latest MLPX News

MLPXGlobal X Funds - Global X MLP & Energy Infrastructure ETF